National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings, 18153-18154 [2017-07619]

Download as PDF Federal Register / Vol. 82, No. 72 / Monday, April 17, 2017 / Notices carbamate), I declared that circumstances exist justifying the authorization of emergency use of injectable treatments for nerve agent or certain insecticide (organophosphorus and/or carbamate) poisoning pursuant to section 564 of the FD&C Act, subject to the terms of any authorization issued under that section. Notice of any EUAs issued by the FDA Commissioner pursuant to this determination and declaration will be provided promptly in the Federal Register as required under section 564 of the FD&C Act. Place: National Institutes of Health, 6701 Rockledge Drive, Room 7178, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: William J. Johnson, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA National Heart, Lung, and Blood Institute 6701 Rockledge Drive, Room 7178, Bethesda, MD 20892–7924, 301–435– 0725, johnsonwj@nhlbi.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) Dated: April 11, 2017. Thomas E. Price, Secretary. Dated: April 11, 2017. Michelle Trout, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2017–07685 Filed 4–14–17; 8:45 am] [FR Doc. 2017–07618 Filed 4–14–17; 8:45 am] BILLING CODE P BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Health National Heart, Lung, and Blood Institute; Notice of Closed Meetings Center for Scientific Review; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. mstockstill on DSK30JT082PROD with NOTICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; TOPMed Informatics Research Center (IRC). Date: May 9, 2017. Time: 1:00 p.m. to 2:30 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, 6701 Rockledge Drive, Room 7178, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: William J. Johnson, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA National Heart, Lung, and Blood Institute 6701 Rockledge Drive, Room 7178, Bethesda, MD 20892–7924, 301–435– 0725, johnsonwj@nhlbi.nih.gov. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; TOPMed Data Coordinating Center (DCC). Date: May 9, 2017. Time: 2:30 p.m. to 5:00 p.m. Agenda: To review and evaluate contract proposals. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR–15– 276: Turkey-US Collaborative Program for Affordable Medical Technologies (R01). Date: May 5, 2017. Time: 1:00 p.m. to 3:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Careen K. Tang-Toth, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6214, MSC 7804, Bethesda, MD 20892, (301) 435– 3504, tothct@csr.nih.gov. VerDate Sep<11>2014 17:14 Apr 14, 2017 Jkt 241001 (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 18153 Dated: April 11, 2017. Michelle Trout, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2017–07617 Filed 4–14–17; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIH Support for Conferences and Scientific Meetings (Parent R13/U13). Date: May 9–11, 2017. Time: 8:30 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health 5601 Fishers Lane, Rockville, MD 20892, (Virtual Meeting). Contact Person: J. Bruce Sundstrom, Ph.D. Scientific Review Official, Scientific Review Program, Division of Extramural Activities, Room 3G11A, National Institutes of Health/NIAID, 5601 Fishers Lane, MSC 9823, Bethesda, MD 20892–9823, (240) 669– 5045, sundstromj@niaid.nih.gov Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID Clinical Trial Implementation Cooperative Agreement (U01/R01). Date: May 10, 2017. Time: 1:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health Rockville, MD 20892 (Telephone Conference Call). Contact Person: Yong Gao, Ph.D. Scientific Review Officer Scientific Review Program, Division of Extramural Activities, Room #3G13B, National Institutes of Health/NIAID, 5601 Fishers Lane, MSC 9823, Rockville, MD 20892–7616, (240) 669–5048, yong.gao@ nih.gov. E:\FR\FM\17APN1.SGM 17APN1 18154 Federal Register / Vol. 82, No. 72 / Monday, April 17, 2017 / Notices (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: April 11, 2017. Natasha M. Copeland, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2017–07619 Filed 4–14–17; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY Federal Emergency Management Agency [Docket ID: FEMA–2017–0011; 1660–0011] Agency Information Collection Activities: Proposed Collection; Comment Request; Debt Collection Financial Statement Federal Emergency Management Agency, DHS. ACTION: Notice. AGENCY: The Federal Emergency Management Agency, as part of its continuing effort to reduce paperwork and respondent burden, invites the general public and other Federal agencies to take this opportunity to comment on a revision of a currently approved information collection. In accordance with the Paperwork Reduction Act of 1995, this notice seeks comments concerning the collection of information related to disaster program accounts and debts owed to FEMA by individuals. SUMMARY: Comments must be submitted on or before June 16, 2017. ADDRESSES: To avoid duplicate submissions to the docket, please use only one of the following means to submit comments: (1) Online. Submit comments at www.regulations.gov under Docket ID FEMA–2017–0011. Follow the instructions for submitting comments. (2) Mail. Submit written comments to Docket Manager, Office of Chief Counsel, DHS/FEMA, 500 C Street SW., 8NE., Washington, DC 20472–3100. All submissions received must include the agency name and Docket ID. Regardless of the method used for submitting comments or material, all submissions will be posted, without change, to the Federal eRulemaking Portal at https://www.regulations.gov, and will include any personal information you provide. Therefore, submitting this information makes it public. You may wish to read the mstockstill on DSK30JT082PROD with NOTICES DATES: VerDate Sep<11>2014 17:14 Apr 14, 2017 Jkt 241001 Privacy Act notice that is available via the link in the footer of www.regulations.gov. FOR FURTHER INFORMATION CONTACT: Jackie Cohen, Chief, Debt Management Unit, FEMA Finance Center, Office of the Chief Financial Officer, FEMA at (540) 504–1650. You may contact the Records Management Division for copies of the proposed collection of information at email address: FEMAInformation-Collections-Management@ fema.dhs.gov. SUPPLEMENTARY INFORMATION: Under the Debt Collection Improvement Act as amended (Pub. L. 104–134), the Federal Claims Collection Standards (31 CFR parts 900–904) and DHS regulations (6 CFR 11); the Administrator of FEMA is: (1) Required to attempt collection of all debts owed to the United States arising out of activities of FEMA; and (2) for debts not exceeding $100,000, authorized to compromise such debts or terminate collection action completely where it appears that that the person liable for such debt does not have the present or prospective financial ability to pay a significant sum, or that the cost of collecting such debt is likely to exceed the amount of recovery (31 U.S.C. 3711(a)(2)). FEMA is revising this collection by requesting additional information on FEMA Form 127–0–1 including the debtor’s phone number and detailed information concerning the debtor’s dependents, including age, relationship, and contribution to the household income, if any. Additionally, FEMA has incorporated Household Expense Listing form questions such as other monthly gross income, monthly housing & utility expenses, monthly transportation expenses, etc. Collection of Information Title: Debt Collection Financial Statement. Type of Information Collection: Revision of a currently approved information collection. OMB Number: 1660–0011. FEMA Forms: FEMA Form 127–0–1, Debt Collection Financial Statement. Abstract: FEMA may request debtors to provide personal financial information on FEMA Form 127–0–1 concerning their current financial position. FEMA uses this information to determine whether to compromise, suspend, or completely terminate collection efforts on respondents’ debts. This information is also used to locate debtor’s assets if the debts are sent for judicial enforcement. Affected Public: Individuals or households. Number of Respondents: 300. PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 Number of Responses: 300. Estimated Total Annual Burden Hours: 225 hours. Estimated Cost: The estimated annual cost to respondents for the hour burden is $7,632.00. There are no annual costs to respondents’ operations and maintenance costs for technical services. There are no annual start-up or capital costs. The cost to the Federal Government is $62,644.00. Comments Comments may be submitted as indicated in the ADDRESSES caption above. Comments are solicited to (a) evaluate whether the proposed data collection is necessary for the proper performance of the agency, including whether the information shall have practical utility; (b) evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (c) enhance the quality, utility, and clarity of the information to be collected; and (d) minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Dated: April 5, 2017. Tammi Hines, Records Management Program Chief (Acting), Mission Support, Federal Emergency Management Agency, Department of Homeland Security. [FR Doc. 2017–07611 Filed 4–14–17; 8:45 am] BILLING CODE 9111–19–P DEPARTMENT OF HOMELAND SECURITY Federal Emergency Management Agency [Docket ID: FEMA–2017–0006; OMB No. 1660–0126] Agency Information Collection Activities: Submission for OMB Review; Comment Request; FEMA Preparedness Grants: Emergency Management Performance Grant (EMPG) Federal Emergency Management Agency, DHS. ACTION: Notice. AGENCY: The Federal Emergency Management Agency (FEMA) will submit the information collection abstracted below to the Office of SUMMARY: E:\FR\FM\17APN1.SGM 17APN1

Agencies

[Federal Register Volume 82, Number 72 (Monday, April 17, 2017)]
[Notices]
[Pages 18153-18154]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-07619]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; NIH Support for Conferences and 
Scientific Meetings (Parent R13/U13).
    Date: May 9-11, 2017.
    Time: 8:30 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health 5601 Fishers Lane, 
Rockville, MD 20892, (Virtual Meeting).
    Contact Person: J. Bruce Sundstrom, Ph.D.
    Scientific Review Official, Scientific Review Program, Division 
of Extramural Activities, Room 3G11A, National Institutes of Health/
NIAID, 5601 Fishers Lane, MSC 9823, Bethesda, MD 20892-9823, (240) 
669-5045, sundstromj@niaid.nih.gov

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; NIAID Clinical Trial Implementation 
Cooperative Agreement (U01/R01).
    Date: May 10, 2017.
    Time: 1:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health Rockville, MD 20892 
(Telephone Conference Call).
    Contact Person: Yong Gao, Ph.D. Scientific Review Officer 
Scientific Review Program, Division of Extramural Activities, Room 
#3G13B, National Institutes of Health/NIAID, 5601 Fishers Lane, MSC 
9823, Rockville, MD 20892-7616, (240) 669-5048, yong.gao@nih.gov.


[[Page 18154]]


(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: April 11, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-07619 Filed 4-14-17; 8:45 am]
 BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.